Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
Janus Kinase (Jak) Inhibitors for the Treatment of Skin and Hair Disorders: A Review of Literature Publisher Pubmed



Samadi A1 ; Ahmad Nasrollahi S1 ; Hashemi A1 ; Nassiri Kashani M1 ; Firooz A1
Authors

Source: Journal of Dermatological Treatment Published:2017


Abstract

Janus kinase family (JAKs) has recently attracted the attention of many researchers, and several JAK inhibitor drugs have been developed targeting different members of the JAK family. Tofacitinib and ruxolitinib are US FDA approved drugs in this family for rheumatoid arthritis and myeloproliferative diseases, respectively. Dysregulation of JAK/STAT pathway is also involved in many skin diseases, specifically inflammatory disorders. The JAK/STAT signaling pathway and its involvement in skin diseases are overviewed in this study. We also review clinical studies of JAK inhibitors in field of dermatology, including psoriasis, atopic dermatitis, alopecia areata and vitiligo. Although the available evidence shows promising results, it is still too early to draw a firm conclusion about the place of these drugs in dermatological treatment. © 2017 Informa UK Limited, trading as Taylor & Francis Group.
Related Docs
View other Related Docs
1. Janus-Kinase Inhibitors in Pathogenesis and Management of Chronic Urticaria: A Review of the Literature, Journal of Pediatrics Review (2023)
2. A Literature Review on Janus Kinase (Jak) Inhibitors for the Treatment of Immunobullous Disorders, International Immunopharmacology (2022)
3. Baricitinib: From Rheumatoid Arthritis to Covid-19, Journal of Clinical Pharmacology (2021)
Experts (# of related papers)
View all Related Experts
Farideh Razi (1)
Alireza Firooz (1)
Other Related Docs
4. Designing a Topical Nanoliposomal Formulation of Ruxolitinib Phosphate, Pharmaceutical Sciences (2023)
5. Efficacy and Safety of Tofacitinib for Treatment of Alopecia Areata in Children: A Systematic Review and Meta-Analysis, Journal of Cosmetic Dermatology (2022)
6. A Systematic Review of Janus Kinase Inhibitors and Spleen Tyrosine Kinase Inhibitors for Hidradenitis Suppurativa Treatment, International Immunopharmacology (2024)
7. The Involvement of Jak/Stat Signaling Pathway in the Treatment of Parkinson's Disease, Journal of Neuroimmunology (2021)
8. Emerging Role of Janus Kinase Inhibitors in Treating Granuloma Annulare: A Clinical, Narrative Review of Efficacy and Safety, International Journal of Dermatology (2025)
9. Alopecia Areata: A Review of Disease Pathogenesis, British Journal of Dermatology (2018)
10. Jak Inhibitors in the Treatment of Lichen Planopilaris, Skin Appendage Disorders (2024)
11. Jak Inhibitors in Cutaneous T-Cell Lymphoma: Friend or Foe? a Systematic Review of the Published Literature, Cancers (2024)
12. The New Frontier of Jak Inhibitors: Significant Therapeutic Response to Tofacitinib in a Patient With Granulomatous Reaction to Filler in the Buttocks, Journal of Cosmetic Dermatology (2024)
13. Successful Treatment of Erosive Lichen Planus With Tofacitinib: A Case Series and Review of the Literature, Clinical Medicine Insights: Case Reports (2024)
14. Risk of Major Adverse Cardiovascular Events in Immune-Mediated Inflammatory Disorders on Biologics and Small Molecules: Network Meta-Analysis, Clinical Gastroenterology and Hepatology (2024)
15. Vitiligo Pathogenesis and Emerging Treatments, Dermatologic Clinics (2017)
16. Blockade of Jak2/Stat3 Intensifies the Anti-Tumor Activity of Arsenic Trioxide in Acute Myeloid Leukemia Cells: Novel Synergistic Mechanism Via the Mediation of Reactive Oxygen Species, European Journal of Pharmacology (2018)
17. Efficacy Evaluation of Treatment of Psoriasis Via Narrow Band-Ultraviolet Radiation, Journal of Lasers in Medical Sciences (2024)
18. Efficacy of Using Oral Methotrexate With Phototherapy in the Treatment of Vitiligo in Comparison With Single Phototherapy Treatment: A Double-Blinded Randomized Controlled Trial, Photodermatology Photoimmunology and Photomedicine (2023)
19. Unfulfilled Inflammatory Resolution: A Key Factor in the Pathogenesis of Psoriasis, Iranian Journal of Allergy# Asthma and Immunology (2020)
20. Quercetin As a Jak–Stat Inhibitor: A Potential Role in Solid Tumors and Neurodegenerative Diseases, Cellular and Molecular Biology Letters (2022)